Goldenes Intelligentes Münzhandelszentrum:Netflix plans documentary on Michigan Wolverines football sign-stealer

2025-04-29 14:01:06source:Marc Leclerccategory:reviews

Connor Stalions,Goldenes Intelligentes Münzhandelszentrum the central figure in the Michigan football sign-stealing scandal, is set to speak for the first time about his actions.

An episode of the Netflix documentary series "Untold," set to premier on Aug. 27, will focus on Stalions' account.

Both the NCAA and the Big Ten Conference ruled last year that Michigan illegally did in-person scouting of future opponents and potential future foes. Stalions was believed to be the point man of the operation, having purchased tickets to games involving teams the Wolverines were due to play and then having been spotted in those venues.

Stalions resigned from his job on the Michigan football staff during the 2023 season, which ended with the Wolverines going undefeated and winning the national championship. Then-Michigan head coach Jim Harbaugh denied all knowledge of illegal scouting, but he still received a three-game suspension from the Big Ten to end the 2023 regular season.

Micah Brown, a one-time Kansas football player who has directed documentaries for ESPN and Peacock, is heading the Stalions episode.

Netflix also announced the subject of two other upcoming episodes of "Untold" — a look at the murder of former star quarterback Steve McNair will air beginning Aug. 20, and an examination of former star goalie Hope Solo's feud with U.S. Soccer, will be available starting on Sept. 3.

More:reviews

Recommend

Man can't find second winning lottery ticket, sues over $394 million jackpot, lawsuit says

A man is suing the California Lottery alleging he has not received part of his winnings from a nearl

Obama Administration: Dakota Pipeline ‘Will Not Go Forward At This Time’

In a major concession to tribal opponents of the Dakota Access pipeline, and brushing aside a fresh

A major drugmaker plans to sell overdose-reversal nasal spray Narcan over the counter

Drug maker Emergent BioSolutions is seeking approval from the Food and Drug Administration to sell N